Genovese Burford & Brothers Wealth & Retirement Plan Management’s Pacific Biosciences PACB Stock Holding History

Genovese Burford & Brothers Wealth & Retirement Plan Management’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-750	Closed	-$3K	–	282
2018 Q2	$3K	Hold	750	–	–	﹤0.01%	391
2018 Q1	$2K	Hold	750	–	–	﹤0.01%	410
2017 Q4	$3K	Hold	750	–	–	0.01%	227
2017 Q3	$3K	Buy	750 +250	+50%	+$1.07K	﹤0.01%	361
2017 Q2	$1K	Hold	500	–	–	﹤0.01%	376
2017 Q1	$3K	Buy	+500	New	+$2.45K	﹤0.01%	384

Other funds holding PACB

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Genovese Burford & Brothers Wealth & Retirement Plan Management's PACB Position: Q3 2018 in Review

Genovese Burford & Brothers Wealth & Retirement Plan Management sold out of Pacific Biosciences (PACB) in Q3 2018, closing a stake of 750 shares — an estimated $3K sold.

Genovese Burford & Brothers Wealth & Retirement Plan Management first reported a position in PACB in Q1 2017 and held it in 6 quarters. The position peaked at $3K in Q2 2018. 118 funds tracked by Wall St. Rank hold PACB as of Q3 2018.

Genovese Burford & Brothers Wealth & Retirement Plan Management reported no remaining Pacific Biosciences position as of Q3 2018 after selling out during the quarter.
Genovese Burford & Brothers Wealth & Retirement Plan Management sold 750 Pacific Biosciences shares in Q3 2018, an estimated $3K.
Genovese Burford & Brothers Wealth & Retirement Plan Management first reported a position in Pacific Biosciences in Q1 2017 and held it in 6 quarters.
Genovese Burford & Brothers Wealth & Retirement Plan Management's Pacific Biosciences position peaked at $3K in Q2 2018.
118 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2018.

Based on Genovese Burford & Brothers Wealth & Retirement Plan Management's 13F filing for Q3 2018, filed 13 Nov 2018.